Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action
Authors:
- Waldemar PruzanskiWPWaldemar Pruzanski
- Eva StefanskiESEva Stefanski
- Lesley G. ElliesLELesley G. Ellies
- Jane E. AubinJane E. Aubin
- Alexander SosASAlexander Sos
- Anthony MelcherAMAnthony Melcher
- 1 June 1991
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 28 (3) , 187-193
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injectionClinical Immunology and Immunopathology, 1990
- Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo.Journal of Experimental Medicine, 1989
- Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cellsBiochemical and Biophysical Research Communications, 1989
- A rapid phospholipase A2 bioassay using14C-oleate-labelledE. coli bacteriasJournal of Molecular Medicine, 1989
- Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.Journal of Experimental Medicine, 1988
- Phagocytosis of bacteria and phospholipid degradationBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1988
- Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shockInflammation Research, 1986
- Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin ResistanceScience, 1986
- Interleukin-1Clinical Infectious Diseases, 1984
- Steroid Receptors in OsteoblastsClinical Orthopaedics and Related Research, 1980